Innovation and economy

A high level of innovation translates into a low cost economy.

Thursday 25 August 2016

Apple's future

Apple's future is dependent upon its ability to maintain the frequency of innovation.

Wednesday 24 August 2016

Bit coins:An innovation whose time has come

Bit coins are an internet currency which also doubles as an international currency.The need for an international currency is dominant.Hence,this is an innovation,whose time has come.It is a typical example of the Innovation tool,DMP Challenge.The value of such a currency is that it can be utilised without the limitations of national currencies and exchange rates.
The underlying block chain technology can also bring about a paradigm shift in person to person collaboration and transactions.

Monday 22 August 2016

Dominance of innovation in Economic news

It is interesting to note that Innovation is inadvertently beginning to occupy centre stage in business news.
Innovations that stood out in today were e-kyc,watson of IBM and GSTN.

Sunday 21 August 2016

India's position on the Global Innovation Index

India has improved its position on the Innovation Index from 81 in 2015 to 66 in 2016.This improvement is due to increased software exports,market sophistication and Corporate R&D.

Friday 19 August 2016

Innovation Support Structure in Vedanta

The innovation support structure in Vedanta consists of a web based platform for generating and exchanging innovation ideas among employees.This platform does the role of an,"Innovation Incubator".In addition to this ,the company has also deployed a financial corpus for incubating selected innovation ideas.

Innovation Support Structure in PWC

Annual innovation contests in the form of,"Concept Cradles"constitute a structure for generating Innovations in PWC.

Thursday 18 August 2016

Cipla: Innovation & Patents

Cipla successfully opposed the grant of a patent to Boehringer for Tiotropium Bromide Monohydrate branded as Spiriva.This is utilized in inhalers.The patent was successfully opposed on the basis that it did not enhance therapeutic efficacy.